Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine

Authors

D. K. Mathias, Johns Hopkins University
J. L. Plieskatt, George Washington UniversityFollow
J. S. Armistead, Johns Hopkins University
Jeffrey M. Bethony, George Washington UniversityFollow
K. B. Abdul-Majid, Johns Hopkins University
A. McMillan, Johns Hopkins University
E. Angov, Walter Reed Army Institute of Research, Silver Spring, MD
M. J. Aryee, Johns Hopkins University
B. Zhan, Baylor College of MedicineFollow
P. Gillespie, Baylor College of Medicine
B. Keegan, Baylor College of MedicineFollow
A. R. Jariwala, George Washington UniversityFollow
W. Rezende, Baylor College of Medicine
M. E. Bottazzi, Baylor College of MedicineFollow
D. G. Scorpio, Johns Hopkins University
P. J. Hotez, Baylor College of MedicineFollow
R. R. Dinglasan, Johns Hopkins University

Document Type

Journal Article

Publication Date

4-2012

Journal

Infection and Immunity

Volume

Volume 80, Issue 4

Inclusive Pages

1606-1614

Keywords

Antibodies--immunology; Antigens; CD13--immunology; Insect Vectors--enzymology; Malaria Vaccines--immunology; Plasmodium vivax--immunology

APA Citation

Mathias, D. K., Plieskatt, J. L., Armistead, J. S., Bethony, J. M., Abdul-Majid, K. B., Mcmillan, A., Angov, E., Aryee, M.J.f, Zhan, B., Gillespie, P., Keegan, B., Jariwala, A.R., Rezende, W., Bottazzi, M.E., Scorpio, D.G., Hotez, P.J., Dinglasan, R. R. (2012). Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine. Infection and Immunity, 80(4), 1606-1614.

Peer Reviewed

1